Autor: "Hamilton SR" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions.
Autorzy:: Figueiredo JC; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Passarelli MN; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, United States of America.
Wei W; Taussig Cancer Institute, The Cleveland Clinic, Cleveland, Ohio, United States of America.
Ahnen DJ; Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Denver, Colorado, United States of America.
Morris JS; Department of Biostatistics, Epidemiology & Informatics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Corley L; Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Mehta T; Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Bartley AN; Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; St. Joseph Mercy Hospital, Ann Arbor, Michigan, United States of America.
McKeown-Eyssen G; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Bresalier RS; Department of Gastroenterology, Hepatology, and Nutrition, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.
Barry EL; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, United States of America.
Goel A; Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Charles A. Sammons Cancer Center, Baylor Research Institute and Sammons Cancer, Dallas, Texas, United States of America.; Department of Pathology, City of Hope National Cancer Center, Duarte, California, United States.
Hernandez Mesa G; Department of Gastroenterology, University Hospital of the Canary Islands, La Laguna, Tenerife, Spain.
Hamilton SR; Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Pathology, City of Hope National Cancer Center, Duarte, California, United States.
Baron JA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Nov 11; Vol. 16 (11), pp. e0258878. Date of Electronic Publication: 2021 Nov 11 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Apoptosis*
Adenoma/*pathology
Colorectal Neoplasms/*pathology
Aged ; Cell Proliferation ; Colorectal Neoplasms/metabolism ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.
Autorzy:: Sepulveda AR; From the 1 Department of Pathology and Cell Biology, Columbia University, New York, NY.
Hamilton SR; 2 Department of Pathology.
Allegra CJ; 5 Division of Hematology and Oncology, University of Florida Medical Center, Gainesville.
Grody W; 6 Departments of Pathology and Laboratory Medicine, Pediatrics, and Human Genetics, UCLA Medical Center, Los Angeles, CA.
Cushman-Vokoun AM; 7 Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha.
Funkhouser WK; 8 Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill.
Kopetz SE; 3 Department of Gastrointestinal (GI) Medical Oncology.
Lieu C; 9 Division of Medical Oncology, University of Colorado Denver School of Medicine, Denver.
Lindor NM; 10 Department of Medical Genetics, Mayo Clinic, Scottsdale, AZ.
Minsky BD; 4 Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston.
Monzon FA; 11 Castle Biosciences, Friendswood, TX.
Sargent DJ; 12 Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
Singh VM; 13 Biocept, San Diego, CA.
Willis J; 14 Department of Pathology, Case Western Reserve University, Cleveland, OH.
Clark J; 15 ASCP Institute for Science, Technology, and Policy, American Society for Clinical Pathology, Washington, DC.
Colasacco C; 16 Laboratory and Pathology Quality Center, College of American Pathologists, Northfield, IL.
Bryan Rumble R; 17 American Society of Clinical Oncology, Alexandria, VA.
Temple-Smolkin R; 18 Association for Molecular Pathology, Bethesda, MD.
B Ventura C; 16 Laboratory and Pathology Quality Center, College of American Pathologists, Northfield, IL.
Nowak JA; From the 1 Department of Pathology and Cell Biology, Columbia University, New York, NY.; 2 Department of Pathology.; 3 Department of Gastrointestinal (GI) Medical Oncology.; 4 Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston.; 5 Division of Hematology and Oncology, University of Florida Medical Center, Gainesville.; 6 Departments of Pathology and Laboratory Medicine, Pediatrics, and Human Genetics, UCLA Medical Center, Los Angeles, CA.; 7 Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha.; 8 Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill.; 9 Division of Medical Oncology, University of Colorado Denver School of Medicine, Denver.; 10 Department of Medical Genetics, Mayo Clinic, Scottsdale, AZ.; 11 Castle Biosciences, Friendswood, TX.; 12 Department of Health Sciences Research, Mayo Clinic, Rochester, MN.; 13 Biocept, San Diego, CA.; 14 Department of Pathology, Case Western Reserve University, Cleveland, OH.; 15 ASCP Institute for Science, Technology, and Policy, American Society for Clinical Pathology, Washington, DC.; 16 Laboratory and Pathology Quality Center, College of American Pathologists, Northfield, IL.; 17 American Society of Clinical Oncology, Alexandria, VA.; 18 Association for Molecular Pathology, Bethesda, MD.; 19 Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, NY.; Pokaż więcej
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2017 May; Vol. 141 (5), pp. 625-657. Date of Electronic Publication: 2017 Feb 06.
Typ publikacji:: Journal Article; Practice Guideline
MeSH Terms:: Biomarkers, Tumor*/genetics
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
ErbB Receptors*/genetics
Pathology, Clinical*
Pathology, Molecular*
Humans ; American Medical Association ; DNA Mutational Analysis ; Evidence-Based Medicine ; Genetic Testing ; Mutation ; Prognosis ; United States ; Systematic Reviews as Topic